Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Appointed director
Inv. presentation
|
|
Medite Cancer Diagnostics, Inc. (MDIT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/06/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/23/2019 |
8-K
| Other Events |
| 04/02/2019 |
15-12G/A
| Form 15-12G/A - Securities registration termination [Section 12(g)]: [Amend] |
| 04/01/2019 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 03/22/2019 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 03/18/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/28/2019 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
| 01/03/2019 |
8-K
| Bankruptcy or Receivership |
| 12/06/2018 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 11/14/2018 |
10-Q
| Quarterly Report for the period ended September 30, 2018 |
| 11/07/2018 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/02/2018 |
SC 13G/A
| BIGGER CAPITAL FUND L P reports a 10% stake in MEDITE Cancer Diagnostics, Inc. |
| 10/31/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/25/2018 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 10/23/2018 |
4
| ABELES JOHN H (Director) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Acquired 40,000 shares
@ $0
Bought 266,667 shares
@ $0.075, valued at
$20k
|
|
| 10/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2018 |
8-K
| Quarterly results |
| 10/01/2018 |
8-K
| Quarterly results |
| 09/06/2018 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 08/27/2018 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
| 08/10/2018 |
10-Q
| Quarterly Report for the period ended June 30, 2018 |
| 07/30/2018 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 07/30/2018 |
4
| Lewis William Austin IV (10% Owner) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Bought 1,100,000 shares
@ $0.075, valued at
$82.5k
|
|
| 07/30/2018 |
4
| Von Rump Stephen L. (CEO / CFO) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Bought 133,333 shares
@ $0.075, valued at
$10k
|
|
| 07/20/2018 |
3
| Von Rump Stephen L. (CEO) has filed a Form 3 on Medite Cancer Diagnostics, Inc. |
| 07/18/2018 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 07/12/2018 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 07/12/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2018 |
4
| ABELES JOHN H (Director) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Bought 400,000 shares
@ $0.075, valued at
$30k
|
|
| 07/05/2018 |
4
| Lewis William Austin IV (10% Owner) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Bought 8,000,000 shares
@ $0.075, valued at
$600k
Bought 1,333,334 shares
@ $0.075, valued at
$100k
|
|
| 06/22/2018 |
10-Q
| Quarterly Report for the period ended March 31, 2018 |
| 05/17/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 05/14/2018 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 05/08/2018 |
4
| FORTUNOFF GREGORY (Director) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Bought 1,333,334 shares
@ $0.75, valued at
$1M
Bought 100,000 convertible notes
@ $0.075, valued at
$7.5k
|
|
|
|
|